Correlation of microvascular fractal dimension with positron emission tomography [11C]-methionine uptake in glioblastoma multiforme: Preliminary findings

Microvascular Research

Volumn 80, Issue 2, 2010, Pages 267-273

  Di Ieva, Antonio ^a,b   Grizzi, Fabio ^b   Tschabitscher, Manfred ^a   Colombo, Piergiuseppe ^b   Casali, Massimiliano ^b   Simonelli, Matteo ^b   Widhalm, Georg ^c   Muzzio, Pier Carlo ^d   Matula, Christian ^c   Chiti, Arturo ^b   Rodriguez y Baena, Riccardo ^b  

^a Medical University of Vienna   (Austria)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Angiogenesis; Box counting algorithm; Brain tumor; Fractal dimension; Glioblastoma multiforme; Microvascular network; PET

Indexed keywords

CD34 ANTIGEN; METHIONINE C 11;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG UPTAKE; FEMALE; FRACTAL ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; MORPHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

EID: 77955387551     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.04.003     Document Type: Article

References (66)

1. Abu-Eid E., Landini G. Quantification of the global and local complexity of the epithelial-connective tissue interface of normal, dysplastic, and neoplastic oral mucosae using digital imaging. Pathol. Res. Pract. 2003, 199:475-482.
2. Bading J.R., Kan-Mitchell J., Conti P.S. System A amino acid transport in cultured human tumor cells: implications for tumor imaging with PET. Nucl. Med. Biol. 1996, 23:779-786.
3. Baish J.W., Jain R.K. Fractals and cancer. Cancer Res. 2000, 60:3683-3688.
4. Baish J.W., Gazit Y., Berk D., Nozue M., Baxter L.T., Jain R.K. Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. Microvasc. Res. 1996, 51:327-346.
5. Bergstrom M., Collins V.P., Ehrin E., Ericson K., Eriksson L., Greitz T., Halldin C., von Holst H., Langstrom B., Lilja A. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J. Comput. Assist. Tomogr. 1983, 7:1062-1066.
6. Bernesen H.J., Rijken P., Hagemeier N.E., van der Kogel A.J. A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites. Microvasc. Res. 1999, 57:244-257.
7. Birner P., Piribauer M., Ingeborg F., Gatterbauer B., Marosi C., Ambros P.F., Ambros I.M., Bredel M., Oberhuber G., Roessler K., Budka H., Harris A.L., Hainfellner J.A. Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes. Brain Pathol. 2003, 13:133-143.
8. Braun V., Dempf S., Weller R., Reske S.N., Schachenmayr W., Richter H.P. Cranial neuronavigation with direct integration of (11) C methionine positron emission tomography (PET) data-results of a pilot study in 32 surgical cases. Acta Neurochir. (Wien) 2002, 144:777-782.
9. Castelli C., Losa G.A. Ultrastructural complexity of nuclear components during early apoptotic phases in breast cancer cells. Anal. Cell. Pathol. 2001, 23:1-9.
10. 18F-FDG PET. Eur. J. Nucl. Med. Mol. Imaging 2002, 29:176-182.
11. Cross S.S. Fractals in pathology. J. Pathol. 1988, 182:1-8.
12. Cross S.S., Start R.D., Silcocks P.B., Bull A.D., Cotton D.W., Underwood J.C. Quantitation of the renal arterial tree by fractal analysis. J. Pathol. 1993, 170:479-484.
13. Di Ieva, A., 2007. Fractal Geometry of the pituitary microvascular network [in Italian]. Dissertation, University of Brescia, Brescia, Italy.
14. Di Ieva A., Grizzi F., Ceva-Grimaldi G., Russo C., Gaetani P., Aimar E., Levi D., Pisano P., Tancioni F., Nicola G., Tschabitscher M., Dioguardi N., Rodriguez y Baena R. Fractal dimension as a quantitator of the microvasculature of normal and adenomatous pituitary tissue. J. Anat. 2007, 211:673-680.
15. Di Ieva A., Grizzi F., Gaetani P., Goglia U., Tschabitscher M., Mortini P., Rodriguez y Baena R. Euclidean and fractal geometry of microvascular network in normal and neoplastic pituitary tissue. Neurosurg. Rev. 2008, 31:271-281.
16. Dollinger J.W., Metzler R., Nonnenmacher T.F. Bi-asymptotic fractals: fractals between lower and upper bounds. J. Phys. A: Math. Gen. 1998, 31:3839-3847.
17. Min/+ Mice. Microsc. Microanal. 2010, 16:73-79.
18. 11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:84-92.
19. Gazit Y., Baish J.W., Safabakhsh N., Leunig M., Baxter L.T., Jain R.K. Fractal characteristics of tumor vascular architecture during tumor growth and regression. Microcirculation 1997, 4:395-402.
20. Goldberger A.L., West B.J. Fractals in physiology and medicine. Yale J. Biol. Med. 1987, 60:421-435.
21. Grizzi F., Colombo P., Barbieri B., Franceschini B., Roncalli M., Chiriva-Internati M., Muzzio P.C., Dioguardi N. Correspondence re: Sabo et al., Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin. Cancer Res. 2001, 7:533-537.
22. Grizzi F., Russo C., Colombo P., Franceschini B., Frezza E.E., Cobos E., Chiriva-Internati M. Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension. BMC Cancer 2005, 5:14.
23. Grizzi F., Colombo P., Taverna G., Chiriva-Internati M., Cobos E., Graziotti P., Muzzio P.C., Dioguardi N. Geometry of human vascular system: is it an obstacle for quantyfing anti-angiogenic therapies?. Appl. Immunohistochem. Mol. Morphol. 2007, 15:134-139.
24. Grizzi F., Franceschini B., Fiamengo B., Russo C., Dioguardi N. Vascular architecture: it is a helpful histopathological biomarker for hepatocellular carcinoma?. J. Zhejiang Univ. Sci. B. 2007, 8:217-220.
25. Grizzi F., Weber C., Di Ieva A. Antiangiogenic strategies in medulloblastoma: reality or mystery?. Pediatr. Res. 2008, 63:584-590.
26. Hand D.J. Measurement: Theory and Practice 2004, Arnold, New York.
27. 11C-methionine PET for differential diagnosis of low grade gliomas. Neurology 1998, 50:1316-1322.
28. Hlatky L., Hahnfeldt P., Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J. Natl. Cancer Inst. 2002, 19:883-893.
29. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58-62.
30. Korkolopoulou P., Patsouris E., Kavantzas N., Konstantinidou A.E., Christodoulou P., Thomas-Tsagli E., Pananikolaou A., Eftychiadis C., Pavlopoulos P.M., Angelidakis D., Rologis D., Davaris P. Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol. Appl. Neurobiol. 2002, 28:57-66.
31. 11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur. J. Nucl. Med. Mol. Imaging 2003, 30:868-873.
32. 11C]l-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin. Cancer Res. 2004, 10:7163-7170.
33. Kubota R., Kubota K., Yamada S., Tada M., Takahashi T., Iwatar R., Tamahashi N. Methionine uptake by tumor issue: a microautoradiographic comparison with FDG. J. Nucl. Med. 1995, 36:484-492.
34. Lakka S.S., Rao J.S. Antiangiogenic therapy in brain tumors. Expert Rev. Neurother. 2008, 8:1457-1473.
35. 3H]methyl]-l-methionine. J. Nucl. Med. 2000, 41:1250-1255.
36. Leon S.P., Folkerth R.D., Black P.M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996, 77:362-372.
37. Losa G.A. The fractal geometry of life. Riv. Biol. 2009, 102:29-60.
38. Losa G.A., Castelli C. Nuclear patterns of human breast cancer cells during apoptosis: characterisation by fractal dimension and co-occurrence matrix statistics. Cell Tissue Res. 2005, 322:257-267.
39. Losa G.A., Nonnenmacher T.F. Self-similarity and fractal irregularity in pathologic tissues. Mod. Pathol. 1996, 9:174-182.
40. Mitterhauser M., Wadsak W., Krcal A., Schmaljohann J., Eidherr H., Schmid A., Viernstein H., Dudczak R., Kletter K. New aspects on the preparation of [11C]Methionine. A simple and fast online approach without preparative HPLC. Appl. Radiat. Isot. 2005, 62:441-445.
41. Miyagawa T., Oku T., Uehara H., Desai R., Beattie B., Tjuvajev J., Blasberg R. "Facilited" amino acid transport in upregulated in brain tumors. J. Cereb. Blood Flow Metab. 1998, 18:500-509.
42. 11C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: a stereotactic image-histology comparison. Neuroimage 2009, 49:2977-2982.
43. Paumgartner D., Losa G., Weibel E.R. Resolution effect on the stereological estimation of surface and volume and its interpretation in terms of fractal dimensions. J. Microsc. 1981, 121:51-63.
44. Pinker K., Noebauer-Huhmann I.M., Stavrou I., Hoeftberger R., Szomolanyi P., Karanikas G., Weber M., Stadlbauer A., Knosp E., Friedrich K., Trattnig S. High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings. AJNR 2007, 28:1280-1286.
45. Plate K.H. Gene therapy of malignant glioma via inhibition of tumor angiogenesis. Cancer Metastasis Rev. 1996, 15:237-240.
46. Plate K.H., Breier G., Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol. 1994, 4:207-218.
47. Preusser M., Heinzl H., Gelpi E., Schonegger K., Haberler C., Birner P., Marosi C., Hegi M., Gorlia T., Hainfellner J.A. Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: poor observer agreement limits clinical utility as prognostic factors. Cancer 2006, 107:162-170.
48. Rigaut J.P. An empirical formulation relating boundary length to resolution in specimens showing "non-ideally fractral" dimensions. J. Microsc. 1984, 133:41-54.
49. Rigaut J.P. Fractals in biological image analysis and vision. Gli oggetti frattali in astrofisica, biologia, fisica e matematica 1984, 111-145. Edizioni Cerfim, Locarno. G.A. Losa, D. Merlini (Eds.).
50. Rigaut J.P., Schoevaert-Brossault A.M., Downs A.M., Landini G. Asymptomatic fractals in the context of grey-scale images. J. Microsc. 1997, 189:57-63.
51. Risser L., Plouraboué F., Steyer A., Cloetens P., Le Duc G., Fonta C. From homogeneous to fractal normal and tumorous microvascular networks in the brain. J. Cereb. Blood Flow Metab. 2007, 27:293-303.
52. Sanchez del Pino M.M., Peterson D.R., Hawkins R.A. Neutral amino acid transport characterization of isolated luminal and abluminal membranes of the blood-brain barrier. J. Biol. Chem. 1995, 270:14913-14918.
53. 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg. Rev. 1999, 22:210-214.
54. Sharma S., Sharma M.C., Gupta D.K., Sarkar C. Angiogenic patterns and their quantitation in high grade astrocytic tumors. J. Neurooncol. 2006, 79:19-30.
55. Souba W.W., Pacitti A.J. How amino acids get into cells: mechanisms, models, menus, and mediators. JPEN J. Parenter. Enteral Nutr. 1992, 16:569-578.
56. Staudenherz A., Wolfsberger S., Killer M., Nasel C., Puig S., Marosi C., Leitha T., Hainfellner J.A. Microvessel density is not crucial for scintigraphic visualization of brain tumor using 99mTc-MIBI. Microvasc. Res. 2004, 67:218-222.
57. Tandle A., Blaze D.G., Libu S.K. Antiangiogenic gene therapy of cancer: recent developments. J. Transl. Med. 2004, 2:22.
58. Taverna G., Colombo P., Grizzi F., Franceschini B., Ceva-Grimaldi G., Seveso M., Giusti G., Piccinelli A., Graziotti P. Fractal analysis of two-dimensional vascularity in primary prostate cancer and surrounding non-tumoral parenchyma. Pathol. Res. Pract. 2009, 205:438-444.
59. Tovi M., Lilja A., Bergstrom M., Ericsson A., Bergstrom K., Hartman M. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol. 1990, 31:417-429.
60. Ullrich R.T., Kracht L., Brunn A., Herholz K., Frommolt P., Miletic H., Deckert M., Heiss W.D., Jacobs A.H. Methyl-l-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. J. Nucl. Med. 2009, 50:1962-1968.
61. Vakoc B.J., Lanning R.M., Tyrrell J.A., Padera T.P., Bartlett L.A., Stylianopoulos T., Munn L.L., Tearney G.J., Fukumura D., Jain R.K., Bouma B.E. Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat. Med. 2009, 10:1219-1223.
62. Weber W.A. Use of PET for monitoring cancer therapy and for predicting outcome. J. Nucl. Med. 2005, 46:983-995.
63. 11C]-methionine uptake in brain tumors: initial results of a comparative study. Eur. J. Nucl. Med. 2000, 27:542-549.
64. Weibel E.R. Design of biological organisms and fractal geometry. Fractals in biology and medicine 1994, vol. I. Birkhaeuser Press, Basel-Berlin-Boston.
65. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med. 1991, 324:1-8.
66. Wesseling P., Ruiter D.J., Burger P.C. Angiogenesis in brain tumors; pathobiological and clinical aspects. J. Neurooncol. 1997, 32:253-265.